Learning to Lead in Mitochondrial Disease
The Academy of Medical Sciences FLIER programme is a unique leadership programme that develops leaders of the future who can create collaborations across academia, industry, the NHS and government to…
The Academy of Medical Sciences FLIER programme is a unique leadership programme that develops leaders of the future who can create collaborations across academia, industry, the NHS and government to…
In last week's WCMR Science Seminar Series, we heard from Dr Katja Menger about the role of topoisomerases in mtDNA maintenance, replication and transcription, and from Dr Mahmoud Fassad who…
In last week's WCMR science seminar, we heard from Dr Kyle Thompson who talked about his progress in studying a case of mitochondrial disease that was identified through the collaborative…
In last week's WCMR Science Seminar, we heard two fantastic talks from Lucie Taylor and Dr Tiago Gomes who shared updates on their research projects. Read on to find out…
In our first WCMR 'Research in Progress' meeting of the 2021-22 session, we heard from Dr Conor Lawless who talked about his research project that involves identifying muscle cells with…
As part of our commitment to nurture and train future leaders in mitochondrial research, students from the WCMR at Newcastle University have recently completed an innovative and bespoke PhD workshop…
The Wellcome Centre for Mitochondrial Research (WCMR) at Newcastle University is delighted to announce it has secured further funding from Wellcome to support its vision until 2024. The Centre, established…
Statement from the Euromit 2020 Organising Committee on the decision to postpone Euromit until 2023. We were looking forward with great pride and anticipation to hosting Euromit 2020 in Newcastle…
Monitoring Mitochondrial Function and Activity During Early Embryo Development. Over the past half a century there has been an increase in the average age of motherhood. Understanding the biology of…
The AIMM (Acipimox in Mitochondrial Myopathy) trial is a clinical trial to determine whether a drug, acipimox, can be used to improve muscle symptoms in patients with mitochondrial myopathy (muscle…